Transgenic rodent models of AD have been created and studied by overexpressing rare human mutations in the amyloid precursor protein (APP) and associated secretase components (Psen1 and Psen2) identified in early-onset FAD and tau mutations causal for frontotemporal dementia [72, 73]. The gene discussed is MAPT; the disease is Alzheimer disease.